SKU(재고 관리 코드):LMA882Ra
Magnetic Luminex Assay Kit for Gastric Inhibitory Polypeptide (GIP) ,etc.
Magnetic Luminex Assay Kit for Gastric Inhibitory Polypeptide (GIP) ,etc.
Product No.
LMA882Ra
Organism Species
Rattus norvegicus (Rat).
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Competitive Inhibition
Assay Length
1.5h
Detection Range
4.88-5000pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 1.627 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Gastric Inhibitory Polypeptide (GIP) ,etc..
No significant cross-reactivity or interference between Gastric Inhibitory Polypeptide (GIP) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Gastric Inhibitory Polypeptide (GIP) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Gastric Inhibitory Polypeptide (GIP) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 87-101 | 93 |
EDTA plasma(n=5) | 88-102 | 93 |
heparin plasma(n=5) | 86-105 | 98 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Gastric Inhibitory Polypeptide (GIP) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Gastric Inhibitory Polypeptide (GIP) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Gastric Inhibitory Polypeptide (GIP) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 95-103% | 79-90% | 96-105% | 80-97% |
EDTA plasma(n=5) | 94-103% | 85-96% | 88-95% | 85-92% |
heparin plasma(n=5) | 87-94% | 85-98% | 96-103% | 87-98% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:GIP) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 50μL standard or sample to each well,
add 10μL magnetic beads,and 50μL Detection Reagent A,incubate 60min at 37°C on shaker;
3. Wash plate on magnetic frame for three times;
4. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
5. Wash plate on magnetic frame for three times;
6. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Scientific Reports | The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlyingsignaling mechanisms in a rat model of diabetes mellitus. pubmed:27721485 |
Obesity surgery | The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. pubmed:28840471 |
Obesity Surgery | Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague … Pubmed:29098544 |
BioMed Research International | Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity |
Diabetes Research and Clinical Practice | Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients Pubmed: 31734225 |
OBESITY SURGERY | The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats Pubmed: 31701411 |
FUTURE SCIENCE | Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes Pubmed:35251693 |
Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
RPA882Ra01 | Recombinant Gastric Inhibitory Polypeptide (GIP) | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA882Ra11 | BSA Conjugated Gastric Inhibitory Polypeptide (GIP) | Immunogen; SDS-PAGE; WB. |
CPA882Ra21 | OVA Conjugated Gastric Inhibitory Polypeptide (GIP) | Immunogen; SDS-PAGE; WB. |
PAA882Ra08 | Polyclonal Antibody to Gastric Inhibitory Polypeptide (GIP) | WB; IHC; ICC; IP. |
PAA882Ra01 | Polyclonal Antibody to Gastric Inhibitory Polypeptide (GIP) | WB; IHC; ICC; IP. |
MAA882Ra21 | Monoclonal Antibody to Gastric Inhibitory Polypeptide (GIP) | WB; IHC; ICC; IP. |
MEA882Ra | Mini Samples ELISA Kit for Gastric Inhibitory Polypeptide (GIP) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CEA882Ra | ELISA Kit for Gastric Inhibitory Polypeptide (GIP) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA882Ra | Magnetic Luminex Assay Kit for Gastric Inhibitory Polypeptide (GIP) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
KSA882Ra11 | ELISA Kit DIY Materials for Gastric Inhibitory Polypeptide (GIP) | Main materials for "Do It (ELISA Kit) Yourself". |